SCHEMBL25545404

SCHEMBL25545404

CC(C)c1sc(Br)nc1-c1ccc(OC(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ F2RL3 Q96RI0 1/20 0.40
▸ DRD1 P21728 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ MAT2A P31153 3/20 0.34
▸ ALOX15 P16050 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ ADAM17 P78536 1/20 0.33
▸ SCN5A Q14524 1/20 0.32
▸ GRM2 Q14416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25545411 0.82 MAPT (0.47) MAPTALDH1A1RAB9AGAAF2RL3
SCHEMBL6909946 0.81 HTR2A (0.39) ALDH1A1
SCHEMBL23791840 0.76 KDM5B (0.40) ALDH1A1GAAF2RL3NPC1
SCHEMBL29224029 0.71 FBP1 (0.41) MAPTALDH1A1RAB9AGAAMEN1
SCHEMBL19626483 0.71 ALDH1A1 (0.64) MAPTALDH1A1RAB9AGAAF2RL3
SCHEMBL23791922 0.70 ALDH1A1 (0.40) MAPTALDH1A1RAB9AMEN1KMT2A
SCHEMBL25545570 0.70 ALDH1A1 (0.46) MAPTALDH1A1RAB9AGAAF2RL3
SCHEMBL23791829 0.69 KDM5B (0.39) MAPTGAASMN1; SMN2ADORA2AADORA1
SCHEMBL3825168 0.68 ALDH1A1 (0.64) MAPTALDH1A1RAB9AGAAHPGD
SCHEMBL23782523 0.68 ADORA2A (0.40) MAPTGAAMEN1KMT2AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118103368-A EIF4E inhibitors and uses thereof 皮克医疗公司 2024-05-28 — — CN disclosed
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 — — US disclosed
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 MAPT 2231/4885ALDH1A1 4776/4885RAB9A 1568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback